Home > PB Ratio > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
PB (Price/Book ) Ratio

The Current P/B Ratio of GLENMARK PHARMACEUTICALS is 3.11.

Share Price ₹1,042.7Apr 18,2024
Market Cap ₹29,425.0 Cr
Book Value₹9,456.3 CrMar2023 - Consolidated Results
Price/Book 3.11xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

Definition & Calculation of PB (Price/Book ) ratio of GLENMARK PHARMACEUTICALS

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of GLENMARK PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹29,425.0 Cr] as on Apr 18,2024

(/) Book Value [ ₹9,456.3 Cr] based on Mar2023 - Consolidated Results

(=) P/B Ratio [ 3.11x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for GLENMARK PHARMACEUTICALS , the investors are currently willing to pay '3.11 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of GLENMARK PHARMACEUTICALS !

The chart below summarizes the trend in P/B Ratio of GLENMARK PHARMACEUTICALS over the last five years.

Historical PB (Price/Book ) ratio chart of GLENMARK PHARMACEUTICALS


PB Ratio Performance Analysis for GLENMARK PHARMACEUTICALS

- GLENMARK PHARMACEUTICALS 's latest p/b ratio is 3.11x.

- GLENMARK PHARMACEUTICALS 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 1.77x.

- GLENMARK PHARMACEUTICALS 's operated at median p/b ratio of 1.39x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GLENMARK PHARMACEUTICALS 's p/b ratio peaked in Mar2019 at 3.26x.

- GLENMARK PHARMACEUTICALS 's p/b ratio hit its five-year low in Mar2020 of 0.96x.


How does GLENMARK PHARMACEUTICALS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
GLENMARK PHARMACEUTICALS 9,456.313.1129,425.0
SUN PHARMACEUTICAL INDUSTRIES LTD55,995.406.50364,015.0
CIPLA LTD23,346.004.66108,809.0
DR REDDYS LABORATORIES LTD23,140.404.3099,408.7
ZYDUS LIFESCIENCES LTD17,515.805.3894,213.7
DIVIS LABORATORIES LTD12,767.107.7398,684.0
MANKIND PHARMA LTD7,435.1612.9296,037.1
TORRENT PHARMACEUTICALS LTD6,198.0713.9186,219.0
LUPIN LTD12,315.605.9072,621.1
AUROBINDO PHARMA LTD26,839.802.4365,326.3
ABBOTT INDIA LTD3,146.0217.6055,366.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs GLENMARK PHARMACEUTICALS 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.43x
Max industry PB 17.60x
Median industry PB 5.90x
Average industry PB 7.68x



You may also like the below Video Courses